Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

By Idelevich Efraim   Karminsky Natalie   Dinerman Michael   Katsenelson Rivka L.   Zvi Nana Ben   Baruch Noa Ben   Biran Haim   Man Sofia   Shani Adi  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 324-329

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication

By Ma Yanlei  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1089-1095

Humana Press, Inc

Access to resources Recommend Favorite

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

By Gyldenkerne Niels   Glimelius Bengt   Frödin Jan Erik   Kjaer Mogens   Pfeiffer Per   Hansen Flemming   Keldsen Nina   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 276-279

Informa Healthcare

Access to resources Recommend Favorite

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin - a randomised crossover trial in advanced colorectal cancer

By Borner M.M.   Schoffski P.   de Wit R.   Caponigro F.   Comella G.   Sulkes A.   Greim G.   Peters G.J.   van der Born K.   Wanders J.   de Boer R.F.   Martin C.   Fumoleau P.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 349-358

Elsevier

Access to resources Recommend Favorite